Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
NCT06608342

Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia

Led by Institute of Hematology & Blood Diseases Hospital, China · Updated on 2024-09-23

20

Participants Needed

1

Research Sites

205 weeks

Total Duration

On this page

Sponsors

I

Institute of Hematology & Blood Diseases Hospital, China

Lead Sponsor

J

Juventas Cell Therapy Ltd.

Collaborating Sponsor

AI-Summary

What this Trial Is About

To observe the efficacy and side effects of autologous hematopoietic stem cell transplantation combined with CD19-CART for adult acute lymphoblastic leukemia, and to evaluate the safety and efficacy of this regimen in the treatment of acute lymphoblastic leukemia.

CONDITIONS

Official Title

Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients with high-risk acute B-lymphoblastic leukemia
  • Complete remission was achieved after induction chemotherapy, and autologous CD19-CAR-T was successfully prepared
  • Eligible for autologous hematopoietic stem cell transplantation
  • No major organ dysfunction
Not Eligible

You will not qualify if you...

  • Combined with malignant tumors of other organs
  • With a serious infection that is not under control
  • Syphilis, AIDS, hepatitis B, hepatitis C, any one of them positive
  • Patients who have had an allergic reaction to the drugs used in this study or similar drugs
  • Other patients deemed unsuitable for inclusion by the investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

NO.288 Nanjing Road,Heping District,Tianjin, Tianjin,

Tianjin, Tianjin Municipality, China, 300000

Actively Recruiting

Loading map...

Research Team

E

erlie EL Jiang

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here